Skip to content
OpenCapital
Get started

10x Genomics, Inc. TXG EV / sales

EV / sales at other companies

TEC
Bio-TechneTECH
6.8×-1.1×
Bruker logo
BrukerBRKR
2×-0.4×
Illumina logo
IlluminaILMN
4.5×+1.4×
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
7.1×+0.7×
Revvity logo
RevvityRVTY
4.4×-0.9×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
3.1×+0.1×

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%—

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Calculated from 10x Genomics, Inc.’s reported figures.

enterprise value/total revenue=3.6×

Based on the most recent quarter.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s EV / sales?
10x Genomics, Inc. (TXG) reported EV / sales of 3.6× in Q1 2026.
How has 10x Genomics, Inc.'s EV / sales changed year-over-year?
10x Genomics, Inc.'s EV / sales increased by 192.2% year-over-year, from 1.2× to 3.6×.
What is the long-term trend for 10x Genomics, Inc.'s EV / sales?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s EV / sales has grown at a -44.8% compound annual growth rate (CAGR), from 50.8× to 2.6×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.